More on ABOS
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.25 |
|
|||
| Open | $2.32 | ||||
| 52 Wk High | $0.23 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $2.38 | ||||
| Day Low | $2.24 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 696,851 | ||||
- Form 4 Acumen Pharmaceuticals, For: Jun 15 Filed by: Porter Derrell
- Form 144 Acumen Pharmaceuticals, Filed by: Porter Derrell
- JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform
- Form 144 Acumen Pharmaceuticals, Filed by: Porter Derrell
- Form 8-K Acumen Pharmaceuticals, For: Jun 12
- ACUMEN Pharmaceuticals nominates two Alzheimer's drug candidates
- Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
- Form 144 Acumen Pharmaceuticals, Filed by: Porter Derrell
- Form 4 Acumen Pharmaceuticals, For: Jun 09 Filed by: Fountain Nathan B
- Form 144 Acumen Pharmaceuticals, Filed by: Fountain Nathan B
Entities mentioned with ABOS
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Stifel | View Related Stories »
- 13G | View Related Stories »
- BTIG | View Related Stories »
- Show More...
